NCT01015703

Open-label Safety and Tolerability Study of CoVaccine HT™ in Healthy Volunteers

A Phase 1, Open-Label, Dose Escalation Study of the Safety and Tolerability of CoVaccine HT™ in Healthy Adult Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: BTG International Inc. · Academic / Other
• Sex: All
• Age: 25 Years – 65 Years
• Healthy volunteers: Accepted

Summary

The study is being conducted to explore the safety and tolerability of CoVaccine HT in healthy male and female volunteers. In this study volunteers will receive intramuscular injections of CoVaccine HT.

Conditions

• Vaccine

Interventions

Type	Name	Description
BIOLOGICAL	CoVaccine HT	intramuscular injection, dose escalation

Timeline

• Start date: 2009-11-01
• Primary completion: 2010-06-01
• Completion: 2010-06-01
• First posted: 2009-11-18
• Last updated: 2014-09-15
• Results posted: 2014-09-15

Locations

1 site across 1 country: United Kingdom